PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 686 of 767

Advanced search
🌍Industryrss.globenewswire.comTier 3 · Secondary coverage

ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President

ARS PharmaceuticalsOriginal source
🇺🇸Researchnews.emory.eduTier 2 · Direct publisher

‘A mentor for everyone’: Patty Brennan honored with Emory College’s Cuttino Award | Emory University | Atlanta GA

Emory University School of MedicineOriginal source
🌍Industryrelmada.comTier 1 · Company source

Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Relmada TherapeuticsOriginal source
🌍Mediacryopak.comTier 2 · Direct publisher

Cryopak Engineering Insights: Common Failure Points in Cold Chain Packaging and Why Operational Execution Matters

CryopakOriginal source
🌍Mediaproscia.comTier 2 · Direct publisher

Reflections on KLAS’ US Digital Pathology Report: What it Means to Be a Long-Term Partner

ProsciaOriginal source
🇺🇸Industrycapsida.comTier 1 · Company source

Capsida to Present Preclinical Data of New Next-Generation, High-Performing Ocular Capsids at ASGCT Annual Meeting

Capsida BiotherapeuticsOriginal source
🇪🇺Associationeucope.orgTier 2 · Direct publisher

EUCOPE concerns on the provisional trilogue agreement of EU Institutions on the Critical Medicines Act (CMA)

EUCOPEOriginal source
🇯🇵Devicesolympus-global.comTier 1 · Company source

Financial Results for Fiscal Year 2026

Olympus MedicalOriginal source
🇺🇸CROcelerion.comTier 2 · Direct publisher

Cocktail DDI Studies: Myths vs. Facts

CelerionOriginal source
🇺🇸Industrycapsida.comTier 1 · Company source

CAP-002 Program Update: A Letter to the STXBP1 Community

Capsida BiotherapeuticsOriginal source
🇺🇸Devicespathai.comTier 1 · Company source

PathAI Advances AISight® Dx with the v2.20 Release: Enhancing Viewer Usability, Workflow Efficiency, and Platform Reliability

PathAIOriginal source
🌍Industryemzorpharma.comTier 1 · Company source

15809 2

Emzor PharmaceuticalOriginal source
🌍Industryadial.comTier 1 · Company source

Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update

Adial PharmaceuticalsOriginal source
🌍CROtrinetx.comTier 2 · Direct publisher

TriNetX Wins the Clinical Trial Innovation Award (and What It Means for the Future of Research)

TriNetXOriginal source
🇺🇸Devicesapyxmedical.comTier 1 · Company source

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx MedicalOriginal source
🇺🇸CDMOagcbio.comTier 2 · Direct publisher

AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases

AGC BiologicsOriginal source
🇺🇸CROir.criver.comTier 2 · Direct publisher

Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

Charles River LaboratoriesOriginal source
🌍Industryuk-cpi.comTier 1 · Company source

Cambridge oncology innovator secures £500k investment to improve cancer drug development accuracy

CPI (Healthcare Innovation)Original source
🇫🇷Researchchu-lyon.frTier 2 · Direct publisher

Chapelle de l'Hôtel-Dieu : la restauration continue avec le transept nord

Hospices Civils de LyonOriginal source
🌍Medialemsurgical.comTier 2 · Direct publisher

The Hard Tissue Catalyst: Why Orthopedic Robotics Will Lead the Autonomous Surgical Paradigm Shift

LEM Surgical (Dynamis Spine Robot)Original source
🌍Industrybicara.comTier 1 · Company source

Journal of Clinical Oncology: Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase 1/1b Trial

Bicara TherapeuticsOriginal source
🇺🇸Industryelementbiosciences.comTier 1 · Company source

Element Biosciences Responds to 10x Genomics Patent Infringement Complaint

Element BiosciencesOriginal source
🌍Regulatorytransceleratebiopharmainc.comTier 1 · Regulatory source

TransCelerate and FDA Advance Work on Streamlined Safety Data Collection for Pragmatic Clinical Trials

TransCelerate BioPharmaOriginal source
🌍Industryorchestrabiomed.comTier 1 · Company source

Strategic Capital Supports Pivotal-Stage Execution

Orchestra BioMedOriginal source
🇺🇸CROmedidata.comTier 2 · Direct publisher

History of Women in Clinical Trials

Medidata SolutionsOriginal source
🌍Mediaseqens.comTier 2 · Direct publisher

CELLforCURE launches a process to find a buyer for its Les Ulis site

SeqensOriginal source
🇺🇸Industryir.codexis.comTier 1 · Company source

Codexis Reports First Quarter 2026 Financial Results

CodexisOriginal source
🇨🇦Researchgenomecanada.caTier 2 · Direct publisher

Genome Canada strengthens leadership for mission-driven delivery

Genome CanadaOriginal source
🌍Regulatorycssp.gob.svTier 1 · Regulatory source

Curso básico para Regentes de Laboratorio Clínico

Consejo Superior de Salud Pública (El Salvador)Original source
🌍CROtrinetx.comTier 2 · Direct publisher

TriNetX® Wins “Clinical Trial Innovation Award” in 10th Annual MedTech Breakthrough Awards Program

TriNetXOriginal source
🇯🇵Industryono-pharma.comTier 1 · Company source

2026年3月期 決算発表

Ono Pharmaceutical NewsOriginal source
🇺🇸Devicesapyxmedical.comTier 1 · Company source

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Apyx MedicalOriginal source
🇺🇸CROir.criver.comTier 2 · Direct publisher

Charles River Laboratories Announces First-Quarter 2026 Results

Charles River LaboratoriesOriginal source
🇩🇰Regulatorylaegemiddelstyrelsen.dkTier 1 · Regulatory source

Operation Pangea XVIII: Global action against falsified medicines and illicit trade

Danish Medicines AgencyOriginal source
🇫🇷Researchchu-lyon.frTier 2 · Direct publisher

Un nouveau protocole pour mettre fin aux allergies alimentaires dès le premier âge

Hospices Civils de LyonOriginal source
🇩🇪Researchcharite.deTier 2 · Direct publisher

Psychedelic substances: Who can they help – and who might they harm?

Charité - Universitätsmedizin Berlin (EN)Original source
🇨🇭CDMOsiegfried.chTier 2 · Direct publisher

Siegfried included in Dow Jones Best-in-Class Europe Index

SiegfriedOriginal source
🇯🇵pharma_equipmentprodcms.ulvac.co.jpTier 2 · Direct publisher

ULVAC Establishes Japan-Based Production for Rare-Earth Magnet Vacuum Melting Furnaces --Orders Expected to Approximately Triple Year on Year, Driven Primarily by Demand in Europe and North America--

Ulvac (Pharma)Original source
🇯🇵Devicessysmex.co.jpTier 1 · Company source

Sysmex Included in S&P Dow Jones Indices’ Global ESG Index for the 10th Consecutive Year

Sysmex (Global)Original source
🇮🇹CDMOflammagroup.comTier 2 · Direct publisher

The Flamma Group Receives Funding from Regione Lombardia in 2026

Flamma GroupOriginal source
🌍Mediaproscia.comTier 2 · Direct publisher

From Glass Slide to Molecular Proxy: The Pathology AI Convergence at AACR 2026

ProsciaOriginal source
🌍Industryrelmada.comTier 1 · Company source

Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026

Relmada TherapeuticsOriginal source
🇫🇷Researchchu-lyon.frTier 2 · Direct publisher

Et vous, avez-vous déjà parlé don d'organes et de tissus ?

Hospices Civils de LyonOriginal source
🌍Regulatorysocra.orgTier 1 · Regulatory source

1087 2

SOCRA SocietyOriginal source
🌍Regulatorycssp.gob.svTier 1 · Regulatory source

Diplomado en Farmacología de los Tratamientos de las Enfermedades Infecciosas, Quimioterapéuticos y Vacunas», entre Asociación MÁS QUE FARMACIA y la Junta de Vigilancia de la Profesión Químico Farmacéutica (JVPQF)

Consejo Superior de Salud Pública (El Salvador)Original source
🌍Regulatorymyscrs.orgTier 1 · Regulatory source

A New Chapter in a Longstanding Partnership: SCRS Supports David Vulcano’s Transition to ACRP CEO

SCRS (Clinical Research Sites)Original source
🌍Industryorthofix.comTier 1 · Company source

Orthofix Therapeutic Solutions: Redefining Recovery

OrthofixOriginal source
🌍Industrycormedix.comTier 1 · Company source

CORMEDIX THERAPEUTICS TO REPORT FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON MAY 14, 2026

CorMedixOriginal source
🌍Industryalloytx.comTier 1 · Company source

Advancing Differentiated Bispecific Antibodies in Autoimmune Disease

Alloy TherapeuticsOriginal source
🌍Industryalloytx.comTier 1 · Company source

Designing Bispecifics That Hold Up in the Real World

Alloy TherapeuticsOriginal source
🇺🇸Devicespathai.comTier 1 · Company source

PathAI and A.C.Camargo Cancer Center announce cooperation to expand digital pathology with AI in Brazil via SUS

PathAIOriginal source
🌍Industrytreace.comTier 3 · Secondary coverage

Nanoplasty®-Dr. W. Cottone

Treace Medical ConceptsOriginal source
🌍Industrytreace.comTier 3 · Secondary coverage

Nanoplasty®-Dr. Sisto

Treace Medical ConceptsOriginal source
🌍Industryrelmada.comTier 1 · Company source

Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026

Relmada TherapeuticsOriginal source
🇫🇷Researchchu-toulouse.frTier 2 · Direct publisher

Travaux d'aménagement du parking P1 sur le site hospitalier de Purpan

CHU de ToulouseOriginal source
🇨🇭CDMObachem.comTier 2 · Direct publisher

Bachem announces changes to the Corporate Executive Committee

Bachem PeptidesOriginal source
🇺🇸Devicesviz.aiTier 1 · Company source

Viz.ai Achieves ISO/IEC 42001 Certification, Setting the Standard for Agentic AI in Healthcare

Viz.aiOriginal source
🌍Industryalloytx.comTier 1 · Company source

Alloy Therapeutics and Institute for Protein Innovation Announce Strategic Collaboration to Advance Next-Generation Antibody Discovery

Alloy TherapeuticsOriginal source
🇺🇸CROmedidata.comTier 2 · Direct publisher

AI Is eCOA’s Greatest Leap Forward, But Only If Applied Where It Matters Most

Medidata SolutionsOriginal source
🌍Regulatoryinfarma.plTier 1 · Regulatory source

Raport: Przyspieszenie badań klinicznych to 257 mln zł dla gospodarki i nowoczesne leczenie dla Polaków

INFARMA PolandOriginal source